Does the progress in diagnosing Leśniowski-Crohn\'s disease correlate with the therapeutic procedures?
Journal Title: Gastroenterology Review - Year 2006, Vol 1, Issue 2
Abstract
The progress in molecular analyses of genetic predisposition to Leśniowski-Crohn’s disease does not correlate with therapeutical progress. There is a constant comparison of “step-up” and “top-down” treatment, more and more often there is a discussion about effectiveness of steroids and benefits of using AZA and 6MP. The medical study proves more indications for biological treatment. There is also a progress in farmacogenetics as a method for prognosing the farmacological effectiveness. Unfortunately there is no really effective method of treatment in Leśniowski-Crohn’s disease. That is the reason why unconventional methods of treatment are taken into consideration.
Authors and Affiliations
Agnieszka Dobrowolska-Zachwieja
Keywords
Related Articles
- EP ID EP107410
- DOI -
- Views 221
- Downloads 0
Surgical treatment of ileocaecal Leśniowski-Crohn\'s disease diagnosed during appendectomy
Treatment of the Leśniowski-Crohn’s disease is still a big challenge for many specialist doctors including surgeons. In this paper surgical treatment of the patients with Leśniowski--Crohn’s disease, localized in ileocae...
Diagnostyka obrazowa guzów neuroendokrynnych trzustki z elementami leczenia radioizotopowego
Częstość występowania guzów neuroendokrynnych trzustki (NET) wynosi od 4 do 12 przypadków na milion na rok. Większość stanowią guzy dobrze zróżnicowane (NETWD, WHO typ I), wśród których dominuje insulinoma oraz guzy nies...
Systemic therapy in the treatment of gastroenteropancreatic neuroendocrine tumors
Neuroendocrine tumors (NET) of the gastrointestinal system represent a group of heterogeneous cancers derived from various endocrine cells located in the stomach, guts and pancreas (GEP). Therapy of GEP NET, due to their...
Rola terapii systemowej w leczeniu guzów neuroendokrynnych układu pokarmowego
Guzy neuroendokrynne (NET) układu pokarmowego stanowią heterogenną grupę nowotworów, wywodzących się z komórek wewnątrzwydzielniczych zlokalizowanych w obrębie żołądka, jelit i trzustki (GEP). Z powodu odrębności biolo...
Gastroenteropancreatic neuroendocrine tumors (GEP NET) - discussion around terminology and classification
Neuroendocrine tumours of the gastroenteropancreatic tract (GEP/NETs) represent a rare and heterogenous group of tumors. Firstly, Oberndorfer in 1907 introduced the term “carcinoid” to describe a group of ileal tumors...